day 1 agenda
Scientific Program | |
Day -1: July (19, 2023) | |
Meeting Hall 1 | |
08:00-09:00 | Registrations Open |
09:00-09:15 | Opening Ceremony |
Keynote Talks | |
09:15-09:45 | Title: DNA Karyometry for Automated Detection of Cancer Cells |
Alfred Bocking, Institute of Cytopathology, Dusseldorf , Germany |
|
09:45-10:15 | Title: TBA |
Pran Datta, UAB Medicine - Hematology Oncology, United States | |
10:15-10:45 | Title: Emerging Technologies in Interventional Oncology |
Thomas Vogl, Frankfurt University Hospital, Germany | |
10:45-11:00 | Group Photo & Refreshment Break |
Morning Session: Session Chairs: Alfred Bocking, Institute of Cytopathology, Germany & Thomas Vogl, Frankfurt University Hospital, Germany |
|
11-00-11:20 | Title: Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy |
Yifan Li, Shanxi Cancer Hospital, China | |
11:20-11:40 | Title: Targeting the Proteolysis of Mammalian SWI/SNF Chromatin Remodeling Complexes for Cancer Therapy |
Hui Zhang, University of Nevada, United States | |
11:40-12:00 | Title: Characterizing the dynamics of phosphoinositide variants in cancers |
Takehiko Sasaki, Tokyo Medical and Dental University, Japan | |
12:00-12:20 | Title: Targeting Wnt signalling at the level of the ligand/receptor in primary and metastatic cancer |
Toby Phesse, Cardiff University, United Kingdom | |
12:20-12:40 | Title: Using dual-loaded liposomal carriers to co-deliver a RanGTP inhibitory peptide and doxorubicin to overcome chemotherapeutic resistance in breast cancer cells. |
Mohamed El-Tanani, Al-Ahliyya Amman, Jordan | |
12:40- 13:00 | Title: Functional Analysis Provides Insight into Missing Heritability |
Scott L. Baughan, Wayne State University, United States | |
13:00-14:00 | Lunch Break |
Afternoon Session Session Chairs: Yifan Li, Shanxi Cancer Hospital, China (&) Pran Datta, UAB Medicine - Hematology Oncology, United States |
|
14:00-14:20 | Title: Dynamic Gene Expression Analysis of Publically Available Gene Expression Data: Identifies Novel Genes Causing Endocrine Resistance in Breast Cancer |
Vahed Maroufy, University of texas Health Science at Houston, United States | |
14:20-14:40 | Title: Targeting tumor-associated macrophages for cancer immunotherapy |
Xiaopei Huang, The Ohio State University, United States | |
14:40-15:00 | Title: Diagnostic performance of 99mTc-HYNIC-PSMA SPECT/CT for biochemically recurrent prostate cancer after radical prostatectomy |
Yongju Gao, Henan Provincial People’s Hospital/Zhengzhou University, China | |
15:00-15:20 | Title: PET/MR for the detection of Cancers of unknown primary site |
Brunela Ronchi, FUESMEN, Argentina | |
15:20-15:40 | Title: Nodule-type pneumonitis mimicking lung abscess or tumor recurrence on chest computed tomography identified as osimertinib-induced pneumonitis: A case report |
Ayumu Otsuki, Kameda Medical Center, Japan | |
15:40-16:00 | Title: Improving Vibrational Spectroscopy Prospects in Frontline Clinical Diagnosis using FTIR |
Debdulal Roy, Swansea University, United Kingdom | |
16:00-16:10 | Refreshment Break |
16:10-16:30 | Title: Variation in age-adjusted prostate cancer incidence rates by race and ethnicity after changes in prostate-specific antigen screening |
Sue M Lai, University of Kansas Medical Center, United States | |
16:30-16:50 | Title: Molecular Characterization of Adenoid Cystic Carcinoma |
Adel K. El-Naggar, The University of Texas, United States | |
16:50-17:10 | Title: CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting |
Kristopher Shawn LyBarger, Sarah Cannon Cancer Center-HCA MidAmerica, United States | |
17:10-17:30 | Title: Crucial proteins involved in Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma |
Matilde Esther, Vall d´Hebron Research Institute, Spain | |
Day-1 Concludes |
day 2 agenda
Scientific Program | |
Day -2: July (20, 2023) | |
Keynote Talks | |
09:00-9:30 | Title: Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals |
Keisuke Fukuchi, DAIICHI SANKYO CO., LTD., Japan | |
9:30-10:00 | Title: Cytochrome c Acetylation in Prostate Cancer: Warburg Effect and Evasion of Apoptosis |
Maik Huettemann, Wayne State University, United States | |
Morning Session Session Chairs: Mohamed El-Tanani, Al-Ahliyya Amman, Jordan (&) Debdulal Roy, Swansea University, United Kingdom |
|
10:00-10:20 | Title: Quantum dots based in-vitro co-culture cancer model for identification of rare cancer cell heterogeneity |
Anupalli Roja Ranii, Osmania University, India | |
10:20-10:40 | Title: Comparison of the functional state and motor skills of patients after cerebral hemisphere, ventricular system, and cerebellopontine angle tumor surgery |
Stanislaw Krajewski, University of Bydgoszcz, Poland | |
10:40-11:00 | Title: Design and standard utilization of safety devices for the radiation treatment management of heavy patients |
David Kanchaveli, Memorial Sloan Kettering Cancer Center, United States | |
11:00-11:20 | Title: LOWER 24- MONTH RELATIVE SURVIVAL AMONG BLACK PATIENTS WITH NON- HODGKIN’S LYMPHOMA: AN ANALYSIS OF THE SEER DATA 1997-2015 |
Maria J Nieto, Northwell Health Cancer Institute, United States | |
11:20-11:40 | Title: Could alkalization of the acidic tumor microenvironment contribute to the outcome of cancer treatment? Meaning and significance of “alkalization therapy for Cancer |
Reo Hamaguchi, Japanese Society on Inflammation and Metabolism in Cancer, Japan | |
11:40-12:00 | Title: New gold (III) cyanide complex TGS121 induces ER stress, proteasome inhibition and death of Ras-hyperactivated cells |
Izabela Mlynarczuk-Bialy, Warsaw Medical University, Poland | |
12:00-12:20 | Title: Drugging the undruggable: Small molecule inhibitors against the RNA Binding protein hnRNP A18 to simultaneously Inhibit Protein Translation and an Immune Checkpoint in Cancers |
France Carrier, University of Maryland, Baltimore, United States | |
12:20-12:40 | Title: A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology |
Mariusz Madej, Crown Bioscience, Netherlands | |
12:40-13:00 | Title: Pediatric Spinal Hemangioblastomas: Clinical Features and Surgical Outcomes of 39 Case |
Wenqing Jia, Beijing Tiantan Hospital, Capital Medical University, China | |
13:00-14:00 | Lunch Break |
Afternoon Session Session Chairs: Izabela Mlynarczuk-Bialy, Warsaw Medical University, Poland & Anupalli Roja Ranii, Osmania University, India |
|
14:00-14:20 | Title: Novel de Novo CDC42 Gene Defect causes Pancytopenia, Recurrent Infection, Poor Wound Healing, Heterotopia of the Brain: expanding the phenotype spectrum |
Wafaa Mohammed AL Suwairi, KAMC-NGHA, Saudi Arabia | |
14:20-14:40 | Title: Associations between nutrition risk scores and sarcopenia in gastrointestinal cancer patients: A cross-sectional study |
Bo Gao, Nanjing University, China | |
14:40-15:00 | SPEAKER SLOT AVAILABLE |
15:00-15:20 | Title: A randomized phase II study of 5-aminolevulinic acid hydrochloride and sodium ferrous citrate for the prevention of nephrotoxicity induced by cisplatin-based chemotherapy of lung cancer |
Motowo Nakajima, SBI Pharmaceuticals, Japan | |
15:20-15:40 | Title: Stromal Factors on Prostate Cancer Differentiation |
Alvin Y Liu, University of Washington, United States | |
15:40-16:00 | Title: Electrochemical immunosensors for detection and monitoring of breast and lung cancers |
Iva Chianella, Cranfield University, United Kingdom | |
16:00-16:10 | Refreshment Break |
16:10-16:30 | Title: Evolution of myeloma treatment patterns during and after COVID-19 pandemic period |
Natalia Neparidze, Yale University/ yale Cancer Center, United States | |
16:30-16:50 | Title: Correlation between serum cox 2 levels and development of hand foot syndrome with capecitabine – an exploratory analysis from the d-torch study |
Akhil Santhosh, All India Institute of Medical Sciences, India | |
16:50-17:10 | Title: The function and mechanism of lncRNA ARHGAP5-AS1 on the Progression of Triple-negative breast cancer |
Qian Zhao, Shanghai JiaoTong University School of Medicine, China | |
17:10-17:30 | SPEAKER SLOT AVAILABLE |
Day-2 Concludes | |
Note: This is the tentative program only and the timings may be subject to change | |
Conference Hotel: Leonardo Royal Hotel Frankfurt Mailander Str. 1, 60598 Frankfurt am Main, Germany |
|
If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com |
Virtual Agenda
Scientific Program | |
Day -1: July (19, 2023) | |
Virtual Presentations (Time zone: CET) | |
11:00-11:20 | Title: Development of a breast cancercase management information platform(BC-CMIP)module based on patient-perceived value |
Yinyin Liang, The Second Affiliated Hospital of Chongqing Medical University, China | |
11:20-11:40 | Title: MKL-1 Induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA mediated glycolysis |
Yuan Wu, Huazhong University of Science and Technology, China | |
11:40-12:00 | SPEAKER SLOT AVAILABLE |
12:00-12:20 | Title: A pan-cancer analysis of the oncogenic role of polypyrimidine tract binding protein 1 (PTBP1) in human tumors |
Huang Qing, Xiamen Huaxia University, China | |
12:20-12:40 | Title: Precise minimally invasive treatment of gastric cancer beyond the indications of endoscopic treatment with novel combined endoscopic and laparoscopic surgery |
Guiyong Peng, Chongqing Southwest Hospita, China | |
12:40-13:00 | Title: AI-assisted Laser-Induced Plasma Spectroscopy for Real-time, In Vivo Skin Cancer detection |
Sung Hyun Pyun, Speclipse, Inc., Korea | |
13:00-13:20 | Title: Intrinsic and chemically-induced daughter number variations in cancer |
Hong XUE, Hong Kong University of Science and Technology, China | |
13:20-13:40 | Title: Assessment of breast cancer risk factors among pre and post-menopausal women |
Ritu Yadav, Maharshi Dayanand University, India | |
13:40-14:00 | Title: Has the COVID-19 pandemic affected the psychological state of Arab cancer patients? |
Norah Abdullah Bazek Madkhali, Jazan university, Saudi Arabia | |
14:00-14:20 | Title: Antibiotic prophylaxis in breast surgery a metaanalysis to identify the optimal strategy to reduce infection rates in breast surgery |
Bader Alali, Mubarak Al Kabeer Hospital, Kuwait | |
14:20-14:40 | Title: Gluten Exorphins Promote Tumorigenesis in In Vitro Models of Human Lymphoma and Carcinoma |
Federico Manai, University of Pavia, Italy | |
14:40-15:00 | Title: Bromodomain-encoding epigenetic factors as potent regulators of cancer stemness |
Patrycja Czerwinska, Poznan University of Medical Sciences, Poland | |
15:00-15:20 | Title: Patients’ pathways to cancer care in Tanzania: documenting and addressing social inequalities in reaching a cancer diagnosis |
Cristina Santos, The Open University, United Kingdom | |
15:20-15:40 | Title: Effects of Bortezomib on the tumor immune microenvironment: Results from salivary gland carcinoma and mesothelioma mouse models |
Camilla Palumbo, University of Rome "Tor Vergata", Italy | |
15:40-16:00 | Title: Characterization of ovarian cancer symptoms in women without ovarian cancer |
Lindsay Beechem, University of Kentucky College of Medicine, United States | |
16:00-16:20 | Title: The humanized monoclonal ant CCR5 antibody blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy |
Richard G Pestell, Baruch S Blumberg Institute, United States | |
16:20-16:40 | Title: Comparing transcriptomic profiles from seven cell lines to elucidate liver metastatic potential |
Lindsay R. Dresang, University of Wisconsin-Stevens Point, United States | |
16:40-17:00 | Title: Anti-prostate cancer bone metastasis Radium223-based therapies a computational/experimental integrated approach |
Stefano Casarin, Houston Methodist Research Institute, United States | |
17:00-17:20 | Title: Evaluation of Alternatives to Logrank test in Immuno-Oncology Trials under Delayed Treatment Effect A Retrospective Analysis in Patients Treated with Anti-PD1/PD-L1 Agents across Solid Tumors |
Pralay Mukhopadhyay, Otsuka America Pharmaceuticals Incorporated, United States | |
17:20-17:40 | Title: Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients. |
Olayinka Adebayo, Johnson & Johnson, United States | |
17:40-18:00 | Title: Assessment of a Peer Physician Coaching Partnership Between a Designated Cancer Center Genetics Service and a Community Cancer Network HospitalPeer Physician Coaching Between a Cancer Genetics Service and Community OncologistsPeer Physician Coaching Between a Cancer Genetics Service and Community Oncologists |
Marianne Dubard-Gault, University of Washington, United States | |
Day-1 Concludes | |
Note: This is the tentative program only and the timings may be subject to change | |
Conference Hotel: Leonardo Royal Hotel Frankfurt Mailander Str. 1, 60598 Frankfurt am Main, Germany |
|
If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com |
Virtual Agenda
Scientific Program | |
Day -2: July (20, 2023) | |
Virtual Presentations (Time zone: CET) | |
11:00-11:20 | Title: Anti-transcriptional intermediary factor 1-γ antibody in cancer-assoicated myositis |
Yoshinori Tanino, Fukushima Medical University, Japan | |
11:20-11:40 | SPEAKER SLOT AVAILABLE |
11:40-12:00 | Title: Assessment of B7-H3 as a potent biomarker for predicting the radiosensitivity of IDH-wildtype Glioblastoma |
Hui Wu, Affiliated Cancer Hospital of Zhengzhou University, China | |
12:00-12:20 | Title: Application of Cytochrome C-Related Genes in Prognosis and Treatment Prediction of Lung Adenocarcinoma |
Min Tang, Chongqing General Hospital, China | |
12:20-12:40 | Title: TAPE-seq: A Cell-Based Method for Predicting Genome-Wide Off-Target Effects of Prime Editor |
Jungjoon Lee, Toolgen, Korea | |
12:40-13:00 | Title: Combination strategies to maximize the benefits of cancer immunotherapy |
Shaoming Zhu, Beijing Chao-Yang Hospital, China | |
13:00-13:20 | Title: INTEGRATION OF CONSOLIDATION CHEMOTHERAPY IN CERVICAL CANCER – THINKING BEYOND |
Fatema Nedham, BDF hospital, Bahrain | |
13:20-13:40 | Title: Mitochondrial enzyme FAHD1 regulates complex II activity in breast cancer cells, and is indispensable for BT-20 cells in vitro |
Alexander Weiss &Andreas Andric, University of Innsbruck, Austria | |
13:40-14:00 | Title: Revolutionizing Cancer Care - Personalized Treatment powered by comprehensive Tumor Profiling in NEBC |
Dörthe Schaffrin-Nabe, Praxis für Hämatologie und Onkologie, Germany | |
14:00-14:20 | Title: Impact of Doxorubicin on Cell-Substrate Topology |
Herbert Schneckenburger, Schneckenburger, Germany | |
14:20-14:40 | Title: The antiproliferative effect of cannabidiol in cancer cells is modulated by its physical state and by growth factors |
Alessia D'Aloia, University of Milano-Bicocca, Italy | |
14:40-15:00 | Title: Investigating the role of non-canoncial Wnt planar cell polarity during normal prostate tissue homeostasis and prostate cancer |
Helen Pearson, Cardiff University, United Kingdom | |
15:00-15:20 | Title: SMAD4 governs a feedforward regulation of the TGF-β-effects in CD8 T cells that contributes to preventing chronic intestinal inflammation, a fertile soil for cancer |
Saidi Soudja, Centre de Recherche en cancérologie de Lyon, France | |
15:20-15:40 | Title: Measurement of Irritability in Cancer Patients |
Amy Zhang, Case Western Reserve University, United States | |
15:40-16:00 | Title: Role of timing of steroid use on clinical outcomes of immune checkpoint inhibitor – A population based study |
Nikita Nikita, Thomas Jefferson University, United States | |
16:00-16:20 | Title: The interplay between apurinic/apyrimidinic endonuclease 1 (APE1) and DNA G-quadruplex (G4) in regulating triple-negative breast cancer (TNBC) metastasis. |
Kishor K. Bhakat, University of Nebraska Medical Center, United States | |
16:20-16:40 | Title: Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer |
Elnaz Naderi, Columbia University Medical center, United states | |
16:40-17:00 | Title: Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma |
Scott A. Weed, West Virginia University Cancer Institute, United States | |
17:00-17:20 | Title: Tissue transglutaminase: a new target at the interface with the ovarian cancer stem cell niche |
Salvatore Condello, Indiana University School of Medicine, United States | |
17:20-17:40 | Title: ChoK-full of potential: Choline kinase in B cell and T cell malignancies |
Ping Xie, Rutgers University, United States | |
17:40-18:00 | Title: Interfering with Lipid Metabolism through Targeting CES1 Sensitizes Hepatocellular Carcinoma for Chemotherapy |
Kai Sun, University of Texas Health Science Center, United States | |
18:00-18:20 | Title:Genomic alterations associated with onset and development of angioimmunoblastic T-cell lymphoma and concomitant hematologic neoplasms |
Shuhua Cheng, Icahn School of Medicine at Mount Sinai, United States | |
18:20-18:40 | Title: New Zealand national retrospective cohort study of survival outcomes of patients with metastatic melanoma receiving immune-checkpoint inhibitors |
Ahmad Sufian Bin Ab Rahman, Linear Clinical Research, Perth, Australia | |
18:40-19:00 | SPEAKER SLOT AVAILABLE |
Day-2 Concludes | |
Note: This is the tentative program only and the timings may be subject to change | |
Conference Hotel: Leonardo Royal Hotel Frankfurt Mailander Str. 1, 60598 Frankfurt am Main, Germany |
|
If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com |